It prolongs survival time in models of focal and global cerebral ischemia, global cerebral ischemia-reperfusion, and hypoxia; improves cerebral function; and reduces the size of cerebral infarction lesions. It is used for the treatment of cerebral disorders caused by ischemia in the acute phase of mild to moderate subarachnoid hemorrhage.